Literature DB >> 34661831

The role of community pharmacists in depression management: a survey of attitudes, practices and perceived barriers.

Rula Shami1, Mohammed Fasihul Alam2, Maguy Saffouh ElHajj3.   

Abstract

Background Community pharmacists play a significant role in depression care. Depression is a health priority in national health strategies around the world, including in Qatar. Objective To describe current practices, attitudes and perceived barriers of community pharmacists towards depression care, and to investigate factors associated with these practices. Setting Community pharmacies in Qatar. Method A cross-sectional online survey using an adapted survey instrument. Scores were measured on a five-point Likert scale. Descriptive univariate and bivariate analyses of study outcomes, followed by multivariate regression examining the association between pharmacists' practices and their attitudes, socio-demographic and professional characteristics. Main outcome measure Pharmacists' scores on self-reported attitudes towards depression and depression care practices and the number of perceived barriers for depression care. Result: 358 pharmacists (response rate 39%) completed the questionnaire. Pharmacists' attitudes to depression were moderately positive (mean score = 3.41, SD = 0.26) but involvement in depression care was very low (mean score = 2.64, SD = 0.94). Three major barriers were lack of access to patients' medical records (83.21%), lack of patients' insight on depression and the importance of treatment (81.85%), and lack of knowledge and training on mental health (79.63%). Female pharmacists and those graduated more than 10 years prior were significantly less involved in depression care compared to their counterparts (practice scores (95% CI) -4.36 (-7.46 to -1.26) and -7.51 (-15.10 to -1.35), respectively), while those who had access to private counselling area were more involved (practice score 3.39 (0.20 to 6.59). Pharmacists' depression practice score was positively associated with attitudes (p = 0.001). Conclusion Pharmacists' moderately positive attitudes were not reflected in their suboptimal depression-care practices. Action from policymakers is needed to improve pharmacists' practices and attitudes to depression.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Attitude; Barrier; Community pharmacist; Depression; Practice

Mesh:

Year:  2021        PMID: 34661831     DOI: 10.1007/s11096-021-01337-9

Source DB:  PubMed          Journal:  Int J Clin Pharm


  45 in total

Review 1.  Chronic disease management for depression in primary care: a summary of the current literature and implications for practice.

Authors:  Nick Kates; Michele Mach
Journal:  Can J Psychiatry       Date:  2007-02       Impact factor: 4.356

2.  Impact of coaching by community pharmacists on drug attitude of depressive primary care patients and acceptability to patients; a randomized controlled trial.

Authors:  Oscar Brook; Hein van Hout; Hugo Nieuwenhuyse; Eibert Heerdink
Journal:  Eur Neuropsychopharmacol       Date:  2003-01       Impact factor: 4.600

3.  Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence.

Authors:  M R DiMatteo; H S Lepper; T W Croghan
Journal:  Arch Intern Med       Date:  2000-07-24

4.  Duration of initial antidepressant treatment and subsequent relapse of major depression.

Authors:  Ross J Baldessarini; Wai Keat Lau; Jordan Sim; Min Yi Sum; Kang Sim
Journal:  J Clin Psychopharmacol       Date:  2015-02       Impact factor: 3.153

Review 5.  The treatment gap in mental health care.

Authors:  Robert Kohn; Shekhar Saxena; Itzhak Levav; Benedetto Saraceno
Journal:  Bull World Health Organ       Date:  2004-12-14       Impact factor: 9.408

6.  Randomized trial of pharmacist interventions to improve depression care and outcomes in primary care.

Authors:  Kam L Capoccia; Denise M Boudreau; David K Blough; Allan J Ellsworth; Dave R Clark; Nancy G Stevens; Wayne J Katon; Sean D Sullivan
Journal:  Am J Health Syst Pharm       Date:  2004-02-15       Impact factor: 2.637

Review 7.  Stigma associated with mental illness and its treatment in the Arab culture: A systematic review.

Authors:  Monica Zolezzi; Maha Alamri; Shahd Shaar; Daniel Rainkie
Journal:  Int J Soc Psychiatry       Date:  2018-07-18

8.  The impact of a person-centred community pharmacy mental health medication support service on consumer outcomes.

Authors:  Sara S McMillan; Fiona Kelly; H Laetitia Hattingh; Jane L Fowler; Gabor Mihala; Amanda J Wheeler
Journal:  J Ment Health       Date:  2017-07-04

9.  Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines.

Authors:  Anthony Cleare; C M Pariante; A H Young; I M Anderson; D Christmas; P J Cowen; C Dickens; I N Ferrier; J Geddes; S Gilbody; P M Haddad; C Katona; G Lewis; A Malizia; R H McAllister-Williams; P Ramchandani; J Scott; D Taylor; R Uher
Journal:  J Psychopharmacol       Date:  2015-05-12       Impact factor: 4.153

10.  The prevalence and burden of psychiatric disorders in primary health care visits in qatar: too little time?

Authors:  Abdulbari Bener; Mohammed T Abou-Saleh; Elnour E Dafeeah; Dinesh Bhugra
Journal:  J Family Med Prim Care       Date:  2015 Jan-Mar
View more
  1 in total

1.  How is mental health care provided through community pharmacies? A quest for improvement.

Authors:  Catarina Samorinha; Ward Saidawi; Basema Saddik; Abduelmula R Abduelkarem; Karem H Alzoubi; Eman Abu-Gharbieh; Hamzah Alzubaidi
Journal:  Pharm Pract (Granada)       Date:  2022-03-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.